Wetumpka Urgent Care

CLIA Laboratory Citation Details

2
Total Citations
6
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 01D2006401
Address 11 Cambridge Drive, Wetumpka, AL, 36093
City Wetumpka
State AL
Zip Code36093
Phone334 567-8633
Lab DirectorLYNDSAY EWING

Citation History (2 surveys)

Survey - June 7, 2023

Survey Type: Standard

Survey Event ID: VN7J11

Deficiency Tags: D5437 D5791

Summary:

Summary Statement of Deficiencies D5437 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(a) Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on a review of the Medonic Hematology analyzer calibration records, the Medonic User Manual and an interview with the Technical Consultant, the laboratory failed to perform and document calibrations with the frequency required by the manufacturer. The laboratory failed to perform two of two calibrations due in 2021. The findings include: 1. A review of the Medonic Hematology analyzer calibration records revealed a calibration performed on 12/11/2020 (reviewed during the previous survey). The next calibration was performed seventeen months later on 5/19/2022. 2. A review of the Medonic User's Manual on page 60 "Section "7: Calibration" revealed, "...Introduction ... It is recommended to calibration the instrument every six months". 3. During an interview on 6/7/2023 at 11:40 AM, the Technical Consultant confirmed the laboratory had no record of the two Medonic calibrations due in 2021. . D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: Based on reviews of Quality Assurance records, Hematology records and the CDS (Clinical Diagnostic Solutions) eCQAP (Clinical Quality Assurance Program) reports, and an interview with the Technical Consultant, the laboratory failed to investigate biases noted in the CDS eCQAP reports for the Hematology Quality Controls (QC) and implement

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 20, 2021

Survey Type: Standard

Survey Event ID: 9FFK11

Deficiency Tags: D2007 D5437 D5793 D6054

Summary:

Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on a review of the API (American Proficiency Institute) Hematology proficiency testing (PT) records, personnel records, and an interview with Testing Personnel #5, the surveyor determined the laboratory failed to ensure proficiency testing samples were rotated between all personnel who performed moderate complexity Hematology testing on patients. This was noted on four of four 2020-2021 survey events reviewed. The findings include: 1. A review of API attestation statements revealed the Laboratory Supervisor had performed all the testing on all three 2020 surveys, and the first 2021 survey, performed from 3/17/2020 through 3/16 /2021, the most current survey. None of the PT testing had been performed by Testing Personnel #1, #2, #3, or #5. The surveyor also reviewed 2019 records, however the attestation statement for 2019 Event 1 was missing, and the 2019 Event 3 attestation statement was not signed by the Laboratory Director or the Testing Personnel 2. A review of the personnel files of testing personnel listed on the Form CMS-209 (Laboratory Personnel Report) revealed TP #2, #3 and #5 had been trained to perform moderate complexity Hematology testing on patients since the previous survey on 1/16 /2019. TP #1 was trained in October 2020, and TP #4 was a new employee trained in 2021. 3. During an interview on 7/20/2021 at 11:45 PM, Testing Personnel #5 reviewed the PT records and confirmed the Laboratory Supervisor had performed all the PT testing in 2020-2021. (The Supervisor was not listed on the Form CMS-209 because she is currently on leave, and the facility does not know if she will return to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- work again.) Testing Personnel #5 did not know who had performed survey Events 1 and 3 in 2019. The surveyor then explained all testing personnel listed on the CMS- Form 209 must periodically participate in the performance of proficiency testing. . D5437 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(a) Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on a review of the Medonic Hematology analyzer calibration records, the Medonic User Manual and an interview with Testing Personnel #5, the laboratory failed to perform and document calibrations as per manufacturer's instructions. This was noted on one of seven calibrations performed in 2019-2021. The findings include: 1. A review of the Medonic Hematology analyzer calibration records revealed only the low control (run three times) was performed after the 3/14/2019 calibration. 2. A review of the Medonic User Manual, under "M-Series Calibration Instructions" revealed "...28. To verify calibration run three levels of control ...". 3. In an interview and review of the calibration records on 7/20/2021 at 1:50 PM, Testing Personnel #5 confirmed the above noted findings. . D5793 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(b)(c) (b) The analytic systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access